Skip to content

Fertility and Temporality in Pediatric Oncology

Fertility and Temporality in Pediatric Oncology

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05048771
Acronym
FERTITOP
Enrollment
300
Registered
2021-09-17
Start date
2021-09-30
Completion date
2024-03-31
Last updated
2021-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood Cancer, Fertility Issues, Psychology, Social

Brief summary

Background: When a cancer is diagnosed in a child, the urgency is to take therapeutic actions. Children and their families face the reality of cancer and the reality of the treatments that, in addition to be overwhelming, might cause infertility. Immediately after the diagnosis, a fertility preservation consultation is proposed to discuss fertility preservation options. In practice, it is often difficult to organize. Several years after the end of treatments, a second information consultation is proposed to inform about fertility, evaluate the fertility status and propose a second line of Fertility Preservation when possible. The literature reflects a lack of knowledge regarding the degree of fertility-related distress among pediatric cancer patients as well as insufficient tools at the disposal of medical doctors and nurses to discuss about reproduction with children and young adolescents. Project objective: Understand how young cancer patients and their parents felt about sterility risk at the diagnostic time and now as cured adolescents. Patients & Methods: 300 patients (15-25 years) from 5 different centers (20 patients per year and per center for 3 years) will be included in this study at the information consultation. They will be surveyed through self-administered questionnaires and semidirected interviews that will 1) retrieve perceptions and emotional being of children during the fertility preservation consultation; 2) assess the decision-making process of parents and family since the fertility preservation consultation through the patient's speech; 3) interview the patients about personal history and experience of cancer and consequences of potential fertility impairment and 4) survey the current experience and projections in the future and evaluate their reaction to the proposition of a second line of Fertility Preservation. Expected results: what points should the doctor / psychologist discuss with pediatric cancer survivors in response to their fertility stress? and how to do it? for better initial and follow-up care to improve their quality of life after cancer.

Interventions

OTHERQuestionnaire

Patients will be surveyed through self-administered questionnaires and semidirected interviews with a psychologist

Sponsors

National Cancer Institute, France
CollaboratorOTHER_GOV
Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
15 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* age between 15 -25 * having been diagnosed with cancer during childhood or adolescence, * having finished the treatments and being in remission for at least 2 years

Exclusion criteria

* Recurrence of cancer at the time of the study * Lack of cognitive autonomy to be able to agree to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the impact of infertility on psychological healthdecember 2023Patients will report the outcomes of the infertility risks on the questionnaire provided in this study. Positive and negative impacts will be questioned.

Secondary

MeasureTime frameDescription
Develop a decision aid tool for clinicians designed to increase referral for fertility preservationdecember 2023Using the factors that facilitate or hinder referral to fertility preservation to create a tool for clinicians designed to increase the referral for fertility preservation of children and adolescents with cancer

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026